首页> PloS one> High Potency VEGFRs/MET/FMS Triple Blockade by TAS-115 Concomitantly Suppresses Tumor Progression and Bone Destruction in Tumor-Induced Bone Disease Model with Lung Carcinoma Cells.

High Potency VEGFRs/MET/FMS Triple Blockade by TAS-115 Concomitantly Suppresses Tumor Progression and Bone Destruction in Tumor-Induced Bone Disease Model with Lung Carcinoma Cells.

导出 OA

翻译打印收藏纠错

第一作者： Hidenori,Fujita

第一单位： Discovery and Preclinical Research Division, Taiho Pharmaceutical Co., Ltd., Tsukuba, Ibaraki, Japan.

作者： Hidenori,Fujita ^[1] ; Akira,Gomori ^[1] ; Yayoi,Fujioka ^[1] ; Yuki,Kataoka ^[1] ; Kenji,Tanaka ^[1] ; Akihiro,Hashimoto ^[1] ; Takamasa,Suzuki ^[1] ; Kenjiro,Ito ^[1] ; Tomonori,Haruma ^[1] ; Hiromi,Yamamoto-Yokoi ^[1] ; Naomoto,Harada ^[1] ; Motomu,Sakuragi ^[1] ; Nobuyuki,Oda ^[1] ; Kenichi,Matsuo ^[1] ; Masaki,Inada ^[2] ; Kazuhiko,Yonekura ^[1]

作者单位： Discovery and Preclinical Research Division, Taiho Pharmaceutical Co., Ltd., Tsukuba, Ibaraki, Japan. ^[1] Department of Biotechnology and Life Science, Tokyo University of Agriculture and Technology, Koganei, Tokyo, Japan. ^[2]